CPT® Code 80424

The CPT® Code 80424 refers to a specific laboratory test known as the glucagon tolerance panel, which is utilized primarily for the diagnosis and monitoring of pheochromocytoma. Pheochromocytoma is a rare type of neuroendocrine tumor that typically arises in the adrenal medulla, the inner part of the adrenal glands. This tumor originates from chromaffin cells, which are responsible for the production of catecholamines, including adrenaline (epinephrine) and noradrenaline (norepinephrine). These hormones play a crucial role in the body's response to stress, helping to regulate vital functions such as heart rate, blood pressure, and metabolism. The glucagon tolerance test is designed to assess the levels of catecholamines in the bloodstream, both at baseline and after the administration of glucagon, a hormone that stimulates the liver to release glucose into the bloodstream. The test begins with the insertion of an intravenous (IV) line, which is a separate procedure that must be reported independently. Following a resting period of at least 30 minutes in a supine position, a baseline blood sample is collected through the IV line to measure the fractionated catecholamines. Subsequently, a dose of glucagon (1 mg) is administered via IV push, and a second blood sample is taken two minutes later to evaluate the response of catecholamine levels to the glucagon injection. The analysis of the serum or plasma samples is performed using quantitative high-performance liquid chromatography, a sophisticated technique that allows for precise measurement of catecholamine concentrations. This test is particularly important as elevated levels of catecholamines can lead to various symptoms, including hypertension, tachycardia, and anxiety, which may occur intermittently and can significantly impact patient health.